Table 2

Baseline demographic and SIPS variables, comparison between converters and non-converters.

VariablesLostConvertersNon-convertersComparison
T/Z/χ2P value
Cases, n211668
Demographic variables
 Age (year), mean (SD)17.7 (3.8)19.4 (5.5)18.2 (4.9)t=0.8860.378
 Male, n (%)9 (42.9)11 (68.8)26 (38.2)χ2=4.8940.027
 Female, n (%)12 (57.1)5 (31.3)42 (61.8)
 Education (year), mean (SD)9.5 (1.9)10.6 (2.4)10.5 (3.1)t=0.0220.982
 Height (cm), mean (SD)170.0 (9.8)168.9 (7.9)165.8 (7.2)t=1.5170.133
 Weight (kg) (mean (SD))61.3 (14.6)58.5 (14.3)56.9 (9.3)t=0.5530.582
 BMI (kg/m2)21.1 (3.9)20.4 (4.2)20.7 (3.0)t=0.3610.719
 If antipsychotic taken (n (%))13 (81.3)42 (61.8)χ2=2.1760.140
 Dose6.4 (2.7)7.8 (4.6)t=1.1010.276
SIPS variables
 Before GAF (mean (SD))78.7 (4.3)77.2 (3.8)79.7 (2.4)t=3.2420.002
 Now GAF (mean (SD))56.1 (5.7)53.1 (5.9)57.7 (5.6)t=2.8970.005
 GAF drop (mean (SD))22.8 (5.9)24.1 (5.3)21.4 (5.3)t=1.7360.087
 SIPS_P (median, mean (SD))10,10.7 (3.1)11, 11.3 (3.6)10,10.2 (3.6)Z=1.0400.302
 SIPS_N (median, mean (SD))12,12.4 (6.5)13,13.7 (4.9)11,11.6 (5.6)Z=1.3560.179
 SIPS_D (median, mean (SD))6,6.4 (3.0)7, 7.3 (2.4)7,6.4 (2.8)Z=1.2670.209
 SIPS_G (median, mean (SD))9,9.2 (3.9)10,10.2 (2.0)10,9.5 (2.5)Z=1.0110.315
 SIPS_TOTAL (median, mean (SD))40,39.2 (12.5)42,42.3 (6.8)35,36.2 (9.7)Z=2.3330.023
  • Dose of antipsychotics was measured using an olanzapine-equivalent dose of antipsychotics.

  • BMI, body mass index; GAF, Global Assessment of Functioning; GAF drop, GAF baseline score that drops from highest in the past year; SD, standard deviation; SIPS, the Structured Interview for Prodromal Syndromes; SIPS_D, scores of disorganisation symptoms scale in SIPS; SIPS_G, scores of general symptoms scale in SIPS; SIPS_N, scores of negative symptoms scale in SIPS; SIPS_P, scores of positive symptoms scale in SIPS; SIPS_TOTAL, total scores of SIPS; t/Z/χ2, t for independent t test, Z for Mann-Whitney U test (non-parametrical test), χ2 for κ test.